0001209191-20-040271.txt : 20200702
0001209191-20-040271.hdr.sgml : 20200702
20200702161510
ACCESSION NUMBER: 0001209191-20-040271
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 201009483
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-30
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
Executive Chairman
Common Stock
2020-06-30
4
S
0
5801
284.14
D
29252
D
Common Stock
2020-06-30
4
S
0
9233
285.11
D
20019
D
Common Stock
2020-06-30
4
S
0
8321
286.13
D
11698
D
Common Stock
2020-06-30
4
S
0
4885
287.23
D
6813
D
Common Stock
2020-06-30
4
S
0
1318
287.91
D
5495
D
Common Stock
2020-06-30
4
S
0
500
289.39
D
4995
D
Common Stock
2020-06-30
4
S
0
2534
290.51
D
2461
D
Common Stock
2020-06-30
4
S
0
200
291.34
D
2261
D
Common Stock
440
I
401(k)
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $284.14 (range $283.60 to $284.59).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $285.11 (range $284.70 to $285.66).
Open market sales reported on this line occurred at a weighted average price of $286.13 (range $285.71 to $286.66).
Open market sales reported on this line occurred at a weighted average price of $287.23 (range $286.74 to $287.73).
Open market sales reported on this line occurred at a weighted average price of $287.91 (range $287.75 to $288.16).
Open market sales reported on this line occurred at a weighted average price of $289.39 (range $289.07 to $289.99).
Open market sales reported on this line occurred at a weighted average price of $290.51 (range $290.12 to $290.87).
Open market sales reported on this line occurred at a weighted average price of $291.34 (range $291.31 to $291.36).
/s/ Sabrina Yohai, Attorney-in-Fact
2020-07-02